Sinocom Pharmaceutical (China) a commercial-stage manufacturer of active pharmaceutical ingredients for traditional Chinese medicinal pharmaceutical companies, closed a $15M Series A financing. Participants include Seavi Advent Private Equity.

Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb